365NEWSX
365NEWSX
Subscribe

Welcome

FDA authorizes emergency use of Regeneron antibody treatment given to Trump - Axios

FDA authorizes emergency use of Regeneron antibody treatment given to Trump - Axios

FDA authorizes emergency use of Regeneron antibody treatment given to Trump - Axios
Nov 22, 2020 27 secs

Please enter a valid email.

Please enter a valid email.

Please enter a valid email.

Please enter a valid email.

Please enter a valid email.

Please enter a valid email.

Please enter a valid email.

Please enter a valid email.

Why it matters: Regeneron's two monoclonal antibodies, casirivimab and imdevimab, are for people who tested positive for the coronavirus and "who are at high risk for progressing to severe COVID-19," including people who are 65 and older, and/or people with certain chronic illnesses, per an FDA statement.

Summarized by 365NEWSX ROBOTS

RECENT NEWS

SUBSCRIBE

Get monthly updates and free resources.

CONNECT WITH US

© Copyright 2024 365NEWSX - All RIGHTS RESERVED